Alteration of liver immunity by increasing inflammatory response during co-administration of methamphetamine and atazanavir.
Conclusion: These results demonstrated that METH and atazanavir had a combined impact on the liver immunity, suggesting that the co-treatment could enhance inflammatory response and suppress NK cell activation via CD48.
PMID: 32249638 [PubMed - as supplied by publisher]
Source: Immunopharmacology and Immunotoxicology - Category: Allergy & Immunology Tags: Immunopharmacol Immunotoxicol Source Type: research
More News: Allergy & Immunology | Genetics | Liver | Methamphetamine | Respiratory Medicine | Study | Urology & Nephrology